Virology

Papers
(The H4-Index of Virology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Growth, detection, quantification, and inactivation of SARS-CoV-2204
The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies170
The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells112
Zika virus-spread, epidemiology, genome, transmission cycle, clinical manifestation, associated challenges, vaccine and antiviral drug development97
SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway80
Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution73
Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity70
Association of viral load with serum biomakers among COVID-19 cases63
Antiviral activity of lycorine against Zika virus in vivo and in vitro55
Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series49
Programmed −1 Ribosomal Frameshifting in coronaviruses: A therapeutic target45
Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants’ interaction with ACE2 to understand the binding affinity and stability42
Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution39
On the road to ending the COVID-19 pandemic: Are we there yet?36
Glial cell response to Epstein-Barr Virus infection: A plausible contribution to virus-associated inflammatory reactions in the brain35
Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-233
Viral polymerase binding and broad-spectrum antiviral activity of molnupiravir against human seasonal coronaviruses32
Characterization and evaluation of the pathogenicity of a natural recombinant transmissible gastroenteritis virus in China31
A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE231
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques30
The pharmacology of plant virus nanoparticles29
Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE229
The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein29
Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan29
A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)29
New insights into the evolutionary features of viral overlapping genes by discriminant analysis28
Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis.28
0.039295196533203